Evidence map›Paper›PMID 20214478›Full record

ArticleThe Journal of infectious diseases2010

Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5.

Kathleen Y Dunphy, Ryan H Senaratne, Mamiko Masuzawa, Lon V Kendall, Lee W Riley

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Investigating the role ofMicrobiology spectrum · 2024
    Article
  3. Cells · 2024
    Article
  4. Article
  5. Cells · 2023
    Article
  6. Article
  7. Article
  8. Metabolites · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Underestimated Manipulative Roles ofFrontiers in immunology · 2019
    Review
  16. Microenvironment ofBioMed research international · 2019
    Article
  17. Review
  18. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kathleen Y DunphyDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA 94720, USA.
Ryan H Senaratne
Mamiko Masuzawa
Lon V Kendall
Lee W Riley
University of California, Berkeley · USColorado State University · US

Funding

MOLECULAR BIOLOGY OF INFECTION WITH M TUBERCULOSISR01AI035266 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI RILEY, LEE W · 1993 to 2002
$781k
Therapeutic vaccine against tuberculosisR21AI063350 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RILEY, LEE W · 2005 to 2006
$412k
NIAID NIH HHS R01AI035266NIAID NIH HHS R21 AI063350
6 · The paper itself

Abstract

One key adaptation that Mycobacterium tuberculosis established to survive long term in vivo is a reliance on lipids as an energy source. M. tuberculosis H37Rv has 36 fadD genes annotated as putative fatty acyl-coenzyme A (CoA) synthetase genes, which encode enzymes that activate fatty acids for metabolism. One such gene, fadD5 (Rv0166), is located within the mce1 operon, a cluster of genes associated with M. tuberculosis persistence. We disrupted the putative fatty acid-binding site of fadD5 in H37Rv M. tuberculosis. No significant differences were found in the growth of the mutant and wild-type strains in vitro in nutrient-rich broth or in activated RAW264.7 cells. However, the fadD5 mutant was diminished in growth in minimal medium containing mycolic acid but not other long-chain fatty acids. C57BL/6 mice infected with the fadD5 mutant survived significantly longer than those infected with the wild type, and the mutant never attained the plateau phase of infection in mouse lungs. Infection in the steady-state phase was maintained for up to 168 days at a level that was 1-2 logs less than that noted in the wild type. These observations raise the rather intriguing possibility that FadD5 may serve to recycle mycolic acids for the long-term survival of the tubercle bacilli.

Indexed as

AnimalsCoenzyme A LigasesCulture MediaCytokinesFatty AcidsGenes, BacterialLungMacrophagesMiceMice, Inbred C57BLMutagenesis, Site-DirectedMycobacterium tuberculosisMycolic AcidsTuberculosis, PulmonaryCoenzyme A LigasesCulture MediaCytokinesFatty AcidsMycolic Acids

Identifiers

PMID20214478
PMCPMC3225055
OpenAlexW2000248841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.